Skip to content

Promotion and Mitigation Factors Leading to Illegal Tobacco Purchases

Promotion and Mitigation Factors Leading to Illegal Tobacco Purchases

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06001840
Enrollment
65
Registered
2023-08-21
Start date
2024-01-04
Completion date
2025-03-31
Last updated
2026-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking, Nicotine Vaping

Brief summary

This study will investigate the effects of promotion factors and mitigation strategies on legal and illegal tobacco purchases for different tobacco-user types.

Detailed description

In the present study, we propose to examine some promotion factors and mitigation strategies and how they impact tobacco product legal and illegal purchases. Specifically, we have developed an Illegal Experimental Tobacco Marketplace (iETM). The iETM permits us to identify the number, type, and characteristics of tobacco users who would seek illegal tobacco products and the conditions that would induce them to seek that option. The critical questions we seek to answer are whether changes in product standards and availability will engender illegal tobacco purchasing as a function of tobacco user type (e.g., exclusive combustible product users, and dual cigarette/NVP users). Understanding the user types and the relevant conditions will inform greater tailoring of policy to diminish consumer interest in an illegal market.

Interventions

BEHAVIORALPromotion factors

In the full nicotine conditions, participants' preferred cigarettes and NVP products will be available in the LETM and preferred cigarettes will be available in the iETM. In the low nicotine conditions, a ban will permit only VLNCs in the LETM and preferred cigarettes will be available in the iETM.

BEHAVIORALMitigation strategies

Penalties: Penalties will be presented as a 60% chance of getting caught making illegal purchases. The consequences of illegal purchases include not receiving any study products from the ETM if they were caught and randomly drew that trial.

Sponsors

Virginia Polytechnic Institute and State University
Lead SponsorOTHER
Medical University of South Carolina
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

We will examine two promotion policies. In the full nicotine conditions, participants' preferred cigarettes and NVP products will be available in the LETM and preferred cigarettes will be available in the iETM. In the low nicotine conditions, a ban will permit only very-low nicotine cigarettes (VLNCs) in the LETM and preferred cigarettes will be available in the iETM. Additionally, we will model three mitigation strategies that may reduce iETM purchases: health communications, availability of nicotine replacement, and penalties. The three mitigation factors will be applied during both promotion policies described above.

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Provide informed consent * Be at least 21 years of age or older * Provide a breath sample for measuring carbon monoxide (CO ≥ 8 ppm) * Stable tobacco use patterns for at least two months For exclusive cigarette smokers: * Smoke at least 10 cigarettes daily and do not use NVPs regularly (no more than 9 times in the last month). * For dual cigarette/NVP users: * Smoke at least 10 cigarettes daily and use NVPs at least 3 times in a week (report use of closed nicotine salt system)

Exclusion criteria

* Have plans to move out of the area * Have a serious or unstable physical or mental health condition * Taking a tobacco cessation medication or medication that interferes with nicotine metabolism, motivation or reinforcement * Report concrete, immediate plans to alter/quit using their usual nicotine products at the beginning of the study * Being pregnant or lactating

Design outcomes

Primary

MeasureTime frameDescription
Percent Budget Spent on Illegal Cigarettes Across Policy Conditions1 dayThe study has 4 policy conditions with combinations of promotion strategy (VLNC standard) and mitigation strategy (penalties), and each combination: No Policy, Penalty only, VLNC only, and Penalty + VLNC. The average percentage of the budget spent on illegal cigarettes across all trials was calculated for each policy scenario.
Percent Budget Spent on Legal Cigarettes Across Policy Conditions1 dayThe study has 4 policy conditions with combinations of promotion strategy (VLNC standard) and mitigation strategy (penalties), and each combination: No Policy, Penalty only, VLNC only, and Penalty + VLNC. The average percentage of the budget spent on legal cigarettes across all trials was calculated for each policy scenario.
Percent Budget Spent on E-cigarettes Across Policy Conditions1 dayThe study has 4 policy conditions with combinations of promotion strategy (VLNC standard) and mitigation strategy (penalties), and each combination: No Policy, Penalty only, VLNC only, and Penalty + VLNC. The average percentage of the budget spent on e-cigarettes across all trials was calculated for each policy scenario.
Percent Budget Spent on Nicotine Replacement Therapy Across Policy Conditions1 dayThe study has 4 policy conditions with combinations of promotion strategy (VLNC standard) and mitigation strategy (penalties), and each combination: No Policy, Penalty only, VLNC only, and Penalty + VLNC. The average percentage of the budget spent on nicotine replacement theray across all trials was calculated for each policy scenario.
Percent Budget Spent on Oral Nicotine/Tobacco Across Policy Conditions1 dayThe study has 4 policy conditions with combinations of promotion strategy (VLNC standard) and mitigation strategy (penalties), and each combination: No Policy, Penalty only, VLNC only, and Penalty + VLNC. The average percentage of the budget spent on oral nicotine/tobacco across all trials was calculated for each policy scenario.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORRoberta Freitas-Lemos, Ph.D.

Fralin Biomedical Research Institute at Virginia Tech Carilion

Baseline characteristics

Characteristic
Age, Continuous44.74 years
STANDARD_DEVIATION 9.02
Education
< 12 years
6 Participants
Education
12 years
16 Participants
Education
13-15 years
25 Participants
Education
16+ years
6 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
52 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
ETM Budget62.3 dollars per week
STANDARD_DEVIATION 26.6
Heavines of Vaping Index (HVI)2.56 units on a scale
STANDARD_DEVIATION 2.29
Heaviness of Smoking Index (HSI)3.81 units on a scale
STANDARD_DEVIATION 2.56
Household Income
$100,000-$154,999
2 Participants
Household Income
$20,000-$39,999
4 Participants
Household Income
$40,000-$64,999
3 Participants
Household Income
$65,000-$99,999
0 Participants
Household Income
Greater than $155,000
0 Participants
Household Income
Less than $19,000
18 Participants
Intention to quit cigarettes6.00 units on a scale
STANDARD_DEVIATION 1.41
Intention to quit e-cigarettes2.24 units on a scale
STANDARD_DEVIATION 2.54
Questionairre on Smoking Urges (QSU)- brief
Cigarettes
49.18 units on a scale
STANDARD_DEVIATION 14.87
Questionairre on Smoking Urges (QSU)- brief
E-cigarettes
17.22 units on a scale
STANDARD_DEVIATION 12.58
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
13 Participants
Race (NIH/OMB)
More than one race
2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
18 Participants
Sex: Female, Male
Female
30 Participants
Sex: Female, Male
Male
11 Participants
Timeline Follow Back (TLFB)- Cigarettes18.83 cigarettes per day
STANDARD_DEVIATION 4.26
Timeline Follow Back (TLFB)- E-cigarettes0.00 mL per day
STANDARD_DEVIATION 0.01

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 270 / 26
other
Total, other adverse events
0 / 270 / 26
serious
Total, serious adverse events
0 / 270 / 26

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026